No Photo Available

Last Update

2015-01-01T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Richard Guarino?

Dr. Richard A. Guarino

HQ Phone: (973) 256-0600

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Oxford Pharmaceutical Services Inc

1 US Highway 46 West

Totowa, New Jersey 07512

United States

Background Information

Employment History

Editor

Informa Healthcare's Fourth Edition of New Drug Approval Process

Director of Clinical Research

Sandoz Inc

Affiliations

Liaison
Food and Drug Administration

Member
Academy of Pharmaceutical Physicians and Investigators

Member
Drug Information Association

Member
The Columbus Foundation

Member
Lupus Erythematosus Foundation

Member
Cystic Fibrosis Foundation

Member
Association of Clinical Research Professionals

Education

M.D.

Oxford

Web References (19 Total References)


Richard A. Guarino, MD; ...

www.hum-molgen.org [cached]

Richard A. Guarino, MD; President, Oxford Pharmaceutical Resources, Inc.

Dr. Richard A. Guarino is President of Oxford Pharmaceutical Resources, Inc., a Consulting Clinical and Regulatory Organization specializing in the planning, implementing and submitting INDs, NDAs, in the CTDs format. Dr, Guarino has 35 years of experience in new drug applications, marketing launches, pharmaceutical and product advertising, and FDA Liaison. He was formerly the President and CEO of Oxford Research International Corp. one of the largest CRO's in the United States. Besides serving as an adjunct professor at Fairleigh Dickinson University, he was a former Director of Clinical Research at Sandoz Pharmaceutical Inc, (Novartis) and held the position of Vice President/Medical Director at Revlon Healthcare Group. He has been acclaimed for his book, New Drug Approval Process, now in its 5th edition. It is the first book ever written to guide and recommend ways to expedite the new drug approval process while following all the requirements of the US Code of Federal Regulations, EU Directives and ICH Guidelines.
Dr. Guarino is a member of many professional societies and associations including the New Jersey and New York Academies of Medicine, The Royal Society of Medicine, the Columbus Citizens Foundation, the Presidential Advisory Cabinet at Fairleigh Dickinson University, the Lupus Erythematosus Foundation, the Cystic Fibrosis Foundation and the Sovereign Military Hospitaller Order of Saint John of Jerusalem of Rhodes and of Malta American Association, USA Drug Information Association (DIA), Association of Clinical Research Professionals (ACRP), and Academy of Pharmaceutical Physicians and Investigators (APPI).


Richard A. Guarino, MD; ...

www.cfpa.com [cached]

Richard A. Guarino, MD; President, Oxford Pharmaceutical Resources, Inc.

Dr. Richard A. Guarino is President of Oxford Pharmaceutical Resources, Inc., a Consulting Clinical and Regulatory Organization specializing in the planning, implementing and submitting INDs, NDAs, in the CTDs format. Dr, Guarino has 35 years of experience in new drug applications, marketing launches, pharmaceutical and product advertising, and FDA Liaison. He was formerly the President and CEO of Oxford Research International Corp. one of the largest CRO's in the United States. Besides serving as an adjunct professor at Fairleigh Dickinson University, he was a former Director of Clinical Research at Sandoz Pharmaceutical Inc, (Novartis) and held the position of Vice President/Medical Director at Revlon Healthcare Group. He has been acclaimed for his book, New Drug Approval Process, now in its 5th edition. It is the first book ever written to guide and recommend ways to expedite the new drug approval process while following all the requirements of the US Code of Federal Regulations, EU Directives and ICH Guidelines.
Dr. Guarino is a member of many professional societies and associations including the New Jersey and New York Academies of Medicine, The Royal Society of Medicine, the Columbus Citizens Foundation, the Presidential Advisory Cabinet at Fairleigh Dickinson University, the Lupus Erythematosus Foundation, the Cystic Fibrosis Foundation and the Sovereign Military Hospitaller Order of Saint John of Jerusalem of Rhodes and of Malta American Association, USA Drug Information Association (DIA), Association of Clinical Research Professionals (ACRP), and Academy of Pharmaceutical Physicians and Investigators (APPI).


Richard A. Guarino, MD; ...

www.cfpa.com [cached]

Richard A. Guarino, MD; President, Oxford Pharmaceutical Resources, Inc.

Dr. Richard A. Guarino is President of Oxford Pharmaceutical Resources, Inc., a Consulting Organization specializing in the planning, implementing and submitting of INDs, NDAs, in CTDs format. Dr, Guarino has 30 years of experience in new drug applications, marketing launches, advertising, and FDA Liaison. He was formerly the President and CEO of Oxford Research International Corp. one of the largest CRO's in the United States. Besides serving as an adjunct professor at Fairleigh Dickinson University, he was a former Director of Clinical Research at Sandoz Pharmaceutical Inc, (Novartis) and held the position of Vice President/Medical Director at Revlon Healthcare Group. He has been acclaimed for his book, New Drug Approval Process, now in its 5th edition. It is the first book ever written to guide and recommend ways to expedite the new drug approval process while following all the requirements of the US Code of Federal Regulations, EU Directives and ICH Guidelines.
Dr. Guarino is a member of many professional societies and associations including the New Jersey and New York Academies of Medicine, The Royal Society of Medicine, the Columbus Citizens Foundation, the Presidential Advisory Cabinet at Fairleigh Dickinson University, the Lupus Erythematosus Foundation, the Cystic Fibrosis Foundation and the Sovereign Military Hospitaller Order of Saint John of Jerusalem of Rhodes and of Malta American Association, USA Drug Information Association (DIA), Association of Clinical Research Professionals (ACRP), and Academy of Pharmaceutical Physicians and Investigators (APPI).


Dr. Richard A. Guarino, ...

www.hum-molgen.org [cached]

Dr. Richard A. Guarino, President, Oxford Pharmaceutical Resources, Inc.


By Richard Guarino, Oxford ...

www.informahealthcarebooks.com [cached]

By Richard Guarino, Oxford Pharmaceutical Resources, Totowa, New Jersey, USA

...
Richard Guarino is President of Oxford Pharmaceuticals, Inc., and was the former CEO of Oxford Research International Corp. He is the editor of Informa Healthcare's Fourth Edition of New Drug Approval Process, the first book to guide and recommend ways to expedite global new drug approval processes while also following meeting federal and industry requirements. Dr. Guarino is a member of the Lupus Erythematosus Foundation, the Cystic Fibrosis Foundation and the Columbus Foundation, Drug Information Association, Association of Clinical Research Professionals, and the Academy of Pharmaceutical Physicians and Investigators.

Similar Profiles

Other People with this Name

Other people with the name Guarino

Dera Guarino
National Aeronautics and Space Administration (NASA)

Richard Guarino
City University of New York

Christina Guarino
Beauty Express Inc.

Nick Guarino
Hilton Garden Inn

Michael Guarino
Architecture Inc

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory